Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Computational approaches to structure-based ligand design.

D Joseph-McCarthy¹

¹Wyeth Research, Biological Chemistry Department, Cambridge, MA 02140, USA. djoseph@genetics.com

Pharmacology & Therapeutics

|December 22, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

All-atom empirical potential for molecular modeling and dynamics studies of proteins.

The journal of physical chemistry. B·2014

Same author

Structure-based optimization of PKCtheta inhibitors.

Biochemical Society transactions·2007

Same author

Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors.

Bioorganic & medicinal chemistry·2005

Same author

Functional group placement in protein binding sites: a comparison of GRID and MCSS.

Journal of computer-aided molecular design·2002

Same author

Use of MCSS to design small targeted libraries: application to picornavirus ligands.

Journal of the American Chemical Society·2001

Same author

A structurally biased combinatorial approach for discovering new anti-picornaviral compounds.

Chemistry & biology·2001

Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026

Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026

Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026

Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026

Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026

Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026

See all related articles

Computational structure-based drug design, though nascent, shows promise. Advances in computing power and data availability are driving new computational methods for drug discovery and binding affinity estimation.

Area of Science:

Medicinal Chemistry
Computational Biology
Drug Discovery

Background:

Computational structure-based drug design (SBDD) emerged in the early 1980s.
SBDD methods are still developing but have achieved some successes.
Increasing computational power and available biological data necessitate advanced SBDD techniques.

Purpose of the Study:

To review recent advancements in computational drug design.
To discuss progress in database searching, docking, de novo design, and binding affinity estimation.

Main Methods:

Review of recent literature on computational drug design techniques.
Analysis of advances in algorithms and methodologies for SBDD.

Main Results:

Related Experiment Videos

Significant progress has been made in computational methods for drug discovery.
Improvements in ligand scoring functions enhance accuracy.
Combinatorial chemistry complements computational approaches.

Conclusions:

The field of SBDD is rapidly evolving with substantial potential for future drug discovery.
Exploiting vast sequence and structural data is crucial for advancing computational drug design.
Continued development of computational techniques is essential for identifying novel therapeutics.